NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease

Standard treatment for advanced non-small cell lung cancer (NSCLC) historically consisted of systemic cytotoxic chemotherapy until the early 2000s, when precision medicine led to a revolutionary change in the therapeutic scenario. The identification of oncogenic driver mutations in EGFR, ALK and ROS...

Descripción completa

Detalles Bibliográficos
Autores principales: Michelotti, Anna, de Scordilli, Marco, Bertoli, Elisa, De Carlo, Elisa, Del Conte, Alessandro, Bearz, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223783/
https://www.ncbi.nlm.nih.gov/pubmed/35743191
http://dx.doi.org/10.3390/ijms23126748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223783/
https://www.ncbi.nlm.nih.gov/pubmed/35743191
http://dx.doi.org/10.3390/ijms23126748

Ejemplares similares